Topics:Human Cloning/In Utero Gene Editing: Difference between revisions
Mauricezaki (talk | contribs) |
Mauricezaki (talk | contribs) |
||
| Line 101: | Line 101: | ||
#:By preventing genetic diseases before birth or treating them at the molecular level, gene editing could reduce the need for long-term medical care, hospitalizations, and drug therapies. Over time, this could lower healthcare costs for individuals, families, and public health systems—shifting the focus from managing disease to preventing it. | #:By preventing genetic diseases before birth or treating them at the molecular level, gene editing could reduce the need for long-term medical care, hospitalizations, and drug therapies. Over time, this could lower healthcare costs for individuals, families, and public health systems—shifting the focus from managing disease to preventing it. | ||
===Arguments Against | ===Arguments Against=== | ||
# Reduced Genetic Diversity | # Reduced Genetic Diversity | ||
#:Human cloning results in a lack of DNA diversity, which could make the population more susceptible to diseases and reduce resilience to environmental changes. | #:Human cloning results in a lack of DNA diversity, which could make the population more susceptible to diseases and reduce resilience to environmental changes. | ||
| Line 112: | Line 112: | ||
# Potential for Misuse | # Potential for Misuse | ||
#:Advanced cloning technologies intended for medical purposes, such as organ transplantation, could be exploited by individuals with malicious intent, leading to ethical and legal dilemmas. | #:Advanced cloning technologies intended for medical purposes, such as organ transplantation, could be exploited by individuals with malicious intent, leading to ethical and legal dilemmas. | ||
== Vote Post-Discussion == | == Vote Post-Discussion == | ||
Revision as of 11:28, 1 April 2025
Human Cloning/In Utero Gene Editing, The debate over in utero gene editing and human cloning combines aspects of biotechnology, ethics, and public policy, raising questions about the boundaries of scientific intervention in human life. Doctoral students were asked to take "Pro", "Con", and "In Between" positions regarding the usefulness and harm of Human Cloning/In Utero Gene Editing.
Team
- Cavallaro, N.
- Simhadri, J.
(authors and sources listed alphabetically)
Arguments
Pro arguments
|
Con arguments
|
|---|
Vote Pre-Discussion Results
|
Discussion Summary
The debate over in utero gene editing and human cloning combines aspects of biotechnology, ethics, and public policy, raising questions about the boundaries of scientific intervention in human life. In utero gene editing, particularly through the CRISPR-Cas9 system, offers the potential to correct harmful genetic mutations in a fetus before birth. This approach could prevent diseases like cystic fibrosis or sickle cell anemia, reducing suffering and potentially improving long-term outcomes. However, safety concerns—especially the risk of off-target effects and long-term health impacts—remain significant. The 2018 case of Chinese scientist He Jiankui, who claimed to have created the first gene-edited babies, sparked global condemnation and highlighted the need for stringent international oversight. Human cloning, while distinct from gene editing, raises similarly complex technical, legal, and ethical questions. Cloning can be divided into two main categories: reproductive cloning and therapeutic cloning. Reproductive cloning aims to create a genetically identical individual and would involve implanting a cloned embryo into a uterus to develop into a full-term baby. This process has never been successfully carried out in humans and is widely opposed due to high failure rates, developmental abnormalities, and serious ethical concerns regarding identity, autonomy, and dignity. In contrast, therapeutic cloning—also known as somatic cell nuclear transfer for stem cell research—creates cloned embryos not to produce a person, but to generate embryonic stem cells genetically matched to a patient. These stem cells hold significant promise for regenerative medicine, potentially allowing for personalized organ and tissue repair without the risk of immune rejection. However, therapeutic cloning remains controversial because it involves the creation and destruction of human embryos. These emerging technologies prompt difficult ethical and societal questions that require careful consideration. Concerns about a future of “designer babies”—where genetic traits are selected or enhanced—raise concerns of eugenics and social inequality. There is growing agreement that international cooperation, public dialogue, and ethical guidelines are essential to ensure responsible progress in these areas.2,4 Ultimately, while these biotechnologies could serve as powerful tools to combat disease and enhance human health, their use must be carefully governed to uphold human rights, dignity, and equity.
Arguments For
- Prevention of Genetic Diseases
- Gene editing technologies like CRISPR offer the ability to correct mutations that cause inherited diseases such as sickle cell anemia, Huntington’s disease, and cystic fibrosis. By making these changes early—potentially even before birth—we can reduce or eliminate the burden of lifelong illnesses, improving health outcomes and quality of life for affected individuals and families.
- Advancements in Regenerative Medicine
- Therapeutic cloning can produce genetically matched stem cells, which could be used to grow tissues or even organs for transplantation. This eliminates the risk of immune rejection and reduces the need for organ donors. In the future, it may enable treatments for conditions like spinal cord injuries, Parkinson’s disease, or heart failure by regenerating damaged tissue.
- Support for Infertile Couples and Reproductive Autonomy
- Reproductive cloning could offer a path to biological parenthood for individuals or couples who cannot conceive using traditional or assisted reproductive technologies. It would expand reproductive options, particularly for those with fertility issues, same-sex couples, or individuals who have lost a child and wish to have a genetically related child again.
- Acceleration of Biomedical Research
- Both gene editing and therapeutic cloning provide powerful tools for studying human development and disease. Creating cloned cells or embryos for research purposes enables scientists to model genetic disorders, understand disease progression, and test potential treatments in ways that are more precise and human-relevant than animal models.
- Potential Cost Savings in Healthcare
- By preventing genetic diseases before birth or treating them at the molecular level, gene editing could reduce the need for long-term medical care, hospitalizations, and drug therapies. Over time, this could lower healthcare costs for individuals, families, and public health systems—shifting the focus from managing disease to preventing it.
Arguments Against
- Reduced Genetic Diversity
- Human cloning results in a lack of DNA diversity, which could make the population more susceptible to diseases and reduce resilience to environmental changes.
- Safety Concerns
- There is insufficient data on the long-term safety and effects of human cloning, posing significant health risks.
- Premature Aging
- Animal studies have shown that clones often experience premature aging due to the use of adult stem cells, potentially leading to shorter lifespans and age-related diseases.
- Increased Risk of Biological Disorders
- Clones may be more prone to genetic abnormalities, including a higher likelihood of developing cancer and other health issues.
- Potential for Misuse
- Advanced cloning technologies intended for medical purposes, such as organ transplantation, could be exploited by individuals with malicious intent, leading to ethical and legal dilemmas.
Vote Post-Discussion
|